Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Percutaneous Intramyocardial Septal Radiofrequency Ablation in Obstructive Hypertrophic Cardiomyopathy on Arrhythmias

NCT06031519 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06031519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06031519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Percutaneous Intramyocardial Septal Radiofrequency Ablation in Obstructive Hypertrophic Cardiomyopathy on Arrhythmias
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 22, 2023
Completion date
August 31, 2024
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, hypertrophic cardiomyopathy